Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
Go back to Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026| Dominion Resources (NYSE: D) | Delayed: 65.84 -0.28 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.12 | 52 Week High | $78.97 | |||
| Open | $65.81 | 52 Week Low | $64.54 | |||
| Day High | $66.36 | P/E | 54.87 | |||
| Day Low | $65.61 | EPS | $1.20 | |||
| Volume | 3,265,304 | |||||
| Ryder System (NYSE: R) | Delayed: 248.44 +1.47 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $246.97 | 52 Week High | $80.15 | |||
| Open | $245.98 | 52 Week Low | $45.12 | |||
| Day High | $250.96 | P/E | 53.66 | |||
| Day Low | $245.98 | EPS | $4.63 | |||
| Volume | 183,181 | |||||
